Back to Search
GARY SHAPIRO, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1558392175Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
34879-20(WI)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
27985(MN)
Research & Publications (20)
Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
PMID 19679174·Brain Res Bull·2010
7-preclinical
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
PMID 19192466·J Clin Psychiatry·2009
4-observational
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
PMID 19318484·Clin Cancer Res·2009
3-trial
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography.
PMID 19067010·Sleep Breath·2009
8-other
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
PMID 19451690·J Clin Invest·2009
7-preclinical
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
PMID 18408761·Oncogene·2008
7-preclinical
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
PMID 18632637·Cancer Res·2008
7-preclinical
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).
PMID 19079597·PLoS One·2008
7-preclinical
Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer.
PMID 18621626·Clin Lung Cancer·2008
3-trial
Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.
PMID 17869258·Atherosclerosis·2008
8-other
Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
PMID 18599562·Invest Ophthalmol Vis Sci·2008
4-observational
A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain).
PMID 18230015·Health Psychol·2008
2-rct
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
PMID 18269927·J Allergy Clin Immunol·2008
4-observational
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
PMID 18758305·J Thorac Oncol·2008
3-trial
Epoetin-alpha: preserving kidney function via attenuation of polymorphonuclear leukocyte priming.
PMID 18548979·Isr Med Assoc J·2008
3-trial
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
PMID 17885756·Cancer Chemother Pharmacol·2008
3-trial
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
PMID 18520291·J Thorac Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 PRINCETON CT
MINNEAPOLIS, MN 55416 - Phone
- (612) 405-2760
Quick Facts
- NPI
- 1558392175
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile